Attune Ensemble™ OTC, a First of its Kind Cancer Well-Being App, is Now Available for Free to Spanish-Speaking Patients
Designed to help patients cope with the emotional symptoms of cancer, Blue Note is excited to bring the Hispanic and Latino community a new cancer-specific wellness app.
OncoHealth and Blue Note Therapeutics Partner to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms
Blue Note and OncoHealth have joined to provide patients coping with cancer oncology-specific mental health care.
Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients
In support of expanding access to cancer-specific digital therapeutics, Blue Note has entered into an exclusive licensing agreement with Bixink for the commercialization of attune™ and DreAMLand™ in South Korea.
Cancer-related distress, which can be defined as any unpleasant feeling, emotion, or experience that affects a cancer patient’s quality of life or ability to cope with cancer diagnosis and treatment, affects millions of people. Fewer than half of those who experience cancer-related distress have access to the mental health care they need to find relief. Blue Note Therapeutics is working to close this gap.Learn more